Article
Variation in the Dopamine-4-Receptor Gene in Patients with Type 1 Diabetes.
Neuroendocrinology - 1 Jan 2023
Słomiński Bartosz, Skrzypkowska Maria, Myśliwiec Małgorzata, Trzonkowski Piotr
Abstract excerpt
INTRODUCTION: Because dopaminergic signaling pathways are one of the regulators of autoimmunity, we hypothesize that the -521C>T DRD4 gene polymorphism may associate with the risk of diabetes mellitus type 1 (DM1) and its comorbidities. METHODS: In this case-control study, we have examined 300 patients with DM1 in comparison to 300 healthy age-matched controls. Utilizing the amplification refractory mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
